Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- ANRO
- Price
- 2.25
- Stock movement down
- -0.02 (-0.88%)
- Company name
- Alto Neuroscience, Inc.
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markkapitalisasie
- 60.92M
- Ondernemingswaarde
- -
- Prys/Verkope
- -
- Prys/Boek
- -
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- -
- Volgende P/E
- -
- PEG
- -
- EPS groei
- -
- 1 jaar opbrengs
- -79.64%
- 3 jaar opbrengs
- -
- 5 jaar opbrengs
- -
- 10 jaar opbrengs
- -
Laaste opgedateer: 2025-08-27
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDE
ANRO betaal nie dividende nie of geen data is ontvang nie
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | - |
| Prys tot OCF | - |
| Prys tot FCF | - |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | - |
| Prys tot Boekwaarde | - |
| EV tot verkope | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANSIËLE
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 2.27 |
| Daaglikse hoog | 2.27 |
| Daaglikse laag | 2.15 |
| Daaglikse volume | 457K |
| Hoogtepunt van alle tye | 21.80 |
| 1j analiseraaming | 10.33 |
| Beta | - |
| EPS (TTM) | - |
| Dividend per aandeel | - |
| Ex-dividend datum | - |
| Volgende verdienste datum | 18 Nov 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| ANRO | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -89.68% | -3.04% |
| Hoogste prysdaling | -91.74% | -56.47% |
| Datum van hoogste daling | 4 Apr 2025 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -60.56% | -11.04% |
| Gemiddelde tyd tot nuwe hoogtepunt | 116 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 345 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
60.92M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Werknemers
76
Beleggerverhoudings
-
SEC lêers
CEO
Land
USA
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Seeking AlphaPersvrystellings
iO Charts is a Seeking Alpha partner